The KSM-66 in Ageless Male Max has been shown to support a reduction in body fat vs just exercise alone MAXIMIZE MUSCLE GAINS: Now you can really take your workouts to the next level
Impact of semaglutide on vasomotor symptoms in postmenopausal women: A cohort study
Research has found that among people who took high doses of semaglutide 2.4mg weekly in combination with lifestyle modifications showed approximately 25 percent greater body weight reduction compared to those on placebo after 68 weeks, akin to real world results seen in clinical practice settings
The findings, published in The New England Journal of Medicine , highlight the potential of GLP-1 receptor agonism combined with amylin analog therapy to deliver clinically meaningful weight loss beyond currently available treatments
Avoid injecting into any veins or muscles semaglutide should only be administered into subcutaneous tissue
While weight loss may occur during treatment, it's important to note that Ozempic is not licensed for weight management in the UK (Wegovy is the brand of semaglutide licensed specifically for weight management)
